Skip to main content
Premium Trial:

Request an Annual Quote

Piet Borst, Jose Baselga, Matt van de Rijn, David Kerr, C. Kent Osborne, Joe Gray


Agendia appointed last week six new members to its clinical and scientific advisory board. The advisors will review early research programs and provide academic and clinical evaluations. The advisory board will be chaired by Piet Borst, emeritus director of the Netherlands Cancer Institute. Members include Jose Baselga, professor of medicine at Vall d'Hebron University Hospital in Barcelona, Spain; Matt van de Rijn, professor of pathology a Stanford University; David Kerr, professor of clinical pharmacology at the University of Oxford in the UK; C. Kent Osborne, professor of medicine at Baylor College of Medicine; and Joe Gray, director of the life sciences division at the Lawrence Berkeley National Laboratory.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.